Comparison of the Efficacy of Generation 1 and 2 Tyrosine Kinase Inhibitors in Non-Small Cell Lung Cancer Patients with EGFR Positive Mutations. Indian Journal of Forensic Medicine & Toxicology [Internet]. 2021 May 17 [cited 2026 May 7];15(3):4316-24. Available from: https://medicopublication.com/index.php/ijfmt/article/view/15970